BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.160
-0.005 (-0.16%)
Jun 29, 2026, 1:01 PM EDT - Market open
BioLineRx Employees
As of December 31, 2025, BioLineRx had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 4 or -14.29% compared to the previous year.
Employees
24
Change (1Y)
-4
Growth (1Y)
-14.29%
Revenue / Employee
$58,417
Profits / Employee
-$329,292
Market Cap
13.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Lunai Bioworks | 29 |
| BioCardia | 21 |
| IN8bio | 18 |
| SeaStar Medical Holding | 17 |
| CalciMedica | 16 |
| Werewolf Therapeutics | 14 |
| Cocrystal Pharma | 10 |
BLRX News
- 4 weeks ago - BioLineRx (BLRX) Q1 2026 Earnings Transcript - The Motley Fool
- 4 weeks ago - BLRX Achieves Key Milestones in Clinical Development and Revenue Growth - GuruFocus
- 4 weeks ago - BioLineRx Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - BioLineRx Earnings release: Q1 2026 - Filings
- 4 weeks ago - BioLineRx reports Q1 EPS 0c vs. (0c) last year - TheFly
- 4 weeks ago - BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - BioLineRx to Present GLIX1 Preclinical Data at ASCO 2026 - GuruFocus
- 5 weeks ago - BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - PRNewsWire